Company Filing History:
Years Active: 2017
Title: Enrico Catalano: Innovator in Tumor Treatment
Introduction
Enrico Catalano is a notable inventor based in Novara, Italy. He has made significant contributions to the field of medicine, particularly in the treatment of tumors resistant to chemotherapy. His innovative approach focuses on enhancing the effectiveness of existing chemotherapeutic treatments.
Latest Patents
Enrico Catalano holds a patent for "Compositions comprising rutin useful for the treatment of tumors resistant to chemotherapy." This patent describes the use of rutin to increase the effectiveness of chemotherapeutic treatments in both human and veterinary medicine, especially in cases where tumors exhibit resistance to current chemotherapeutics.
Career Highlights
Catalano is associated with Probiotical S.p.a., a company that emphasizes research and development in health-related products. His work has been instrumental in advancing therapeutic options for patients facing challenging medical conditions.
Collaborations
Enrico collaborates with esteemed colleagues such as Franco Frascini and Marcello Iriti. Their combined expertise contributes to the innovative research and development efforts at Probiotical S.p.a.
Conclusion
Enrico Catalano's contributions to the field of tumor treatment highlight the importance of innovation in medicine. His work continues to pave the way for more effective therapies for patients battling resistant tumors.